PSS34 - COST-EFFECTIVENESS OF INTRAVITREAL AFLIBERCEPT VERSUS RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR EDEMA IN SPAIN
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2534
https://www.valueinhealthjournal.com/article/S1098-3015(18)35836-4/fulltext
Title :
PSS34 - COST-EFFECTIVENESS OF INTRAVITREAL AFLIBERCEPT VERSUS RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR EDEMA IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35836-4&doi=10.1016/j.jval.2018.09.2534
First page :
Section Title :
Open access? :
No
Section Order :
1886